For pharmaceutical and medical device manufacturers of all sizes, it is important to stay on top of the latest regulations. Is your organization prepared for the expansion to CMS Open Payments? Are you aware of the latest changes to other US and global reporting jurisdictions rules and HCP engagement requirements?
MediSpend’s Legislative Watch puts the information you need at your fingertips. Let our experts help keep you informed of important changes.
To learn more, please provide us your information to access the MediSpend webinar “Legislative Watch Update”. In this webinar, our experts provide viewers with updates on transparency reporting and HCP engagement regulations in the United States and globally. Highlights include:
US legislation, including:
Expansion of CMS Open Payments
- CMS COVID-19 Impact Statement
- OIG Fraud Alert Regarding Speaker Programs
- Maine Gift Ban
- Massachusetts Updated Reporting Format
Global developments, including:
- French Anti-Gift Rules
- New Reporting Law in Lithuania
- Transposition of National Codes in line with EFPIA
- Italian Sunshine Act Status
- Updates to global transparency/HCP engagement rules, including New Zealand and the Philippines
…and a sneak peek of the upcoming expansion to MediSpend’s Legislative Watch!
About MediSpend
MediSpend is a global technology company providing best-in-class solutions that enable life science companies to compliantly manage high-risk business functions through top-rated software and client services. MediSpend is the compliance system of record for some of the world’s largest pharmaceutical, medical device, dental and emerging biotech companies around the world. The MediSpend Global Compliance Suite represents the industry’s first global SaaS solution purpose-built to manage the end-to-end process of HCP engagement through transparency reporting, which includes software that facilitates external grant requests. MediSpend is headquartered in Portsmouth, N.H., with offices in Minnesota, New York, Pennsylvania and the Netherlands.